Etanercept

Details

Files

Generic Name:

Etanercept

Project Status:

Complete

Therapeutic Area:

Rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis

Manufacturer:

Sandoz Canada Inc.

Call for patient/clinician input open:

January 5, 2017

Brand Name:

Erelzi

Project Line:

Reimbursement Review

Project Number:

SE0513-000

Call for patient/clinician input closed:

February 24, 2017

NOC Status at Filing:

Pre NOC

Submission Type:

Initial

Indications:

Ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, rheumatoid arthritis

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

July 25, 2017

Last Updated : January 5, 2017